Evidence map›Paper›PMID 38123544›Full record

ReviewTranslational psychiatry2023

Rediscovering tandem repeat variation in schizophrenia: challenges and opportunities.

Rebecca Birnbaum

Open access · goldAbstract readReview
In one paragraph

Review in Translational psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Rebecca BirnbaumDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA. rebecca.birnbaum@mssm.edu.ORCID 0000-0002-4206-4323
Icahn School of Medicine at Mount Sinai · US

Funding

A Functional Investigation of Structural Variants Associated with SchizophreniaK23MH112955 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BIRNBAUM, REBECCA · 2018 to 2022
$795k
NIMH NIH HHS K23 MH112955
6 · The paper itself

Abstract

Tandem repeats (TRs) are prevalent throughout the genome, constituting at least 3% of the genome, and often highly polymorphic. The high mutation rate of TRs, which can be orders of magnitude higher than single-nucleotide polymorphisms and indels, indicates that they are likely to make significant contributions to phenotypic variation, yet their contribution to schizophrenia has been largely ignored by recent genome-wide association studies (GWAS). Tandem repeat expansions are already known causative factors for over 50 disorders, while common tandem repeat variation is increasingly being identified as significantly associated with complex disease and gene regulation. The current review summarizes key background concepts of tandem repeat variation as pertains to disease risk, elucidating their potential for schizophrenia association. An overview of next-generation sequencing-based methods that may be applied for TR genome-wide identification is provided, and some key methodological challenges in TR analyses are delineated.

Indexed as

Genome-Wide Association StudySchizophreniaGenome, HumanHumansPolymorphism, Single NucleotideTandem Repeat Sequences

Identifiers

PMID38123544
PMCPMC10733427
OpenAlexW4389993430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.